SUMMARY Thirty-three patients with early peripheral synovitis were followed up for two to four years in order to study the relationship between fluctuations in rheumatoid factor (RF) levels and indices of clinical activity. Twenty-eight of these patients developed classical/definite rheumatoid arthritis (RA). Seventeen patients developed erosive disease of their hands and wrists and thirteen had a positive RF agglutination test. Nineteen patients had raised levels of IgM, RF, IgA, RF, or IgG RF as measured by isotype-specific ELISA techniques. The within-patient fluctuations in IgA RF levels correlated significantly with the corresponding fluctuations in grip strength (p<0-05), erythrocyte sedimentation rate (ESR) (p<0-01), and a composite index of disease activity (p<002). IgG RF levels were also associated with changes in ESR and grip strength, but IgM RF showed only a weak association with fluctuations in ESR and not with any other clinical parameters. It is suggested that serum IgA RF may be a useful marker of disease activity in rheumatoid arthritis.
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Rheumatoid factors (RF) of the agglutinating type occur in over 75% of rheumatoid arthritis (RA) patients,' and intracellular IgG RF 7 and recent progress in solid phase immunoassay techniques has enabled the development of isotype-specific RF assays.8 9
The aim of this prospective study on early RA was to define more closely the relationship between Accepted for publication 10 Forty-six patients entered the study. Of these, 33 were followed up for a minimum of 24 months from the onset of their symptoms. Of the remaining 13, who did not complete a two-year follow-up, two died (one from lung cancer, the other from myocardial infarction), three moved out of the UK, and eight were lost to follow-up. Six of these eight had no joint symptoms when last seen. Unless otherwise stated, the following analysis is based exclusively on the 33 patients, followed for two years or more. Table 1 shows the age and sex distribution of the group. There were 21 females and 12 males, a female/male ratio of 1-8. The mean age at the onset of symptoms was 52-9 years, age range 22-80 years. Twenty-eight patients met five or more of the ARA criteria for RA'4 at some stage during the follow-up.
These were classified as RA (classical/definite) and the remaining five as non-RA (Table 1) .
Seventeen of the 28 RA patients (61%) developed erosive disease of their hands and wrists during the follow-up ( Table 1 ). The time from the onset of symptoms until the date of the last x-ray ranged from 24 to 48 months. However, there was no significant correlation between the duration of disease and the number of erosions in the RA group (p> 005, r=0-37, Pearson's product-moment correlation method). Eight of the RA patients required gold (sodium aurothiomalate) treatment, and Table 1 shows that six of these eight also required penicillamine and one azathioprine during the follow-up. All these eight and six other RA patients, 50% of the RA group, were treated with oral steroids (low dose prednisolone) at some stage during the follow up. The decision to treat with the 'specific' drugs or steroids was based on conventional criteria, such as persistent synovitis with disabling symptoms despite full treatment with non-steroidal anti-inflammatory drugs and progression of bone erosions on x-ray.
RHEUMATOID FACTOR PROFILES
Thirteen of the group of 33 (39%) were seropositive (titre > 1/40) on one or more occasion in the RAHA agglutination test for RF17 and thus met the 8th ARA criterion for seropositivity. All these 13 developed classical/definite RA, and the frequency of seropositivity in the RA group was therefore 46%.
A total of 651 serum and synovial fluid samples were collected from the patients of the study and assayed by ELISA for IgM RF, IgA RF, and IgG RF as described elsewhere.1) With the results expressed as net absorbance, the IgA RF levels showed an overall highly significant association with IgM RF (r=0-676, n=651, p<0-001, Pearson's product-moment correlation method). Furthermore, the IgM RF levels showed a significant overall correlation with IgG RF (r=0.407, n=643, p<O-00l, Pearson's product-moment correlation method).
Raised levels of IgM RF, IgA RF, or IgG RF as measured by ELISA were observed at some stage in 19 (58%) of the group of 33. When the five non-RA patients were excluded, 18/28 (64%) developed raised RF at some stage. Table 2 shows the frequency of raised individual RF isotypes as measured by ELISA at the first visit, 4-7 ± 3-0 months (mean ± 1 SD) after the onset of symptoms. Seven Table 2 The frequency ofraised RFlevels in the prospective study group of33, both at onset and during the follow-up (Fig. 2) . Table 3 shows the summarised results of a similar analysis where the within-patient association of fluctuations in EMS, PVAS, RAI, GS, ESR, IgA RF, and IgM RF for the group of 33 was studied.
The table shows the mean ± SD of the rsV/n-1 values and the significance of the deviation from zero of the mean rsV'n-l. The fluctuations of the different clinical parameters for each patient were closely associated. For example, the interrelation of PVAS and RAI had a mean rsAV'--1 of 0-96 ± 1-00 (t=5-18, p<O001, Student's t test). Similarly, the fluctuations of GS were closely associated with those of RAI and PVAS (p<0-001). The fluctuations in ESR closely followed those of GS (mean rs\/n-1 + 1 SD of -0-87 ± 1-11, p<0001). The fluctuations in ESR also showed a significant association with those of RAI (0-55 ± 1-07, p<0-05) but there was no significant association between ESR and PVAS or EMS.
The fluctuations of the RF isotypes showed various interesting features. The fluctuation of IgA RF correlated closely with that of ESR (0-57 ±0-96, p<0.01), and there was also significant association between fluctuations in IgA RF and GS (-0-41 ± 1-02, p<0.05), indicating that as GS deteriorated IgA RF tended to rise and vice versa.
The fluctuations of IgG RF also showed a significant correlation with those of ESR (p<0-02) and GS (p<0-05). However, there was no significant association between the fluctuations of IgG RF and IgA RF.
The fluctuations of IgM RF correlated significantly with those of IgA RF (0.60 ± 1-22, p<0-01) and ESR (p<0-05) but not with fluctuations of the clinical parameters (Table 3) . IgA RF tThe mean and standard deviation of the normalised rank coefficients (r,Vn-1). *The significance of the deviation of x from zero as assessed by the Student's t test.
four patients never had any early morning stiffness during the study. Consequently, the number behind each rs5/iV-involving EMS never exceeded 29.
The relationship between the correlation coefficients (r,) for parameters X vs. Y and the absolute values of X and Y during the study period was examined by a multivariate correlation analysis, employing Spearman's rank correlation method. The strength of the association was generally not related to the initial, mean, or maximal values of the parameters involved during the study period. For example, there was no significant correlation between the rs\/n-1 values for the association between
IgA RF and IDA and the initial IgA RF values.
Discussion
The natural course of RA is extremely variable, from one brief attack of synovitis which may barely meet conventional criteria for definite RA to severe, destructive relentlessly progressive disease. It may therefore be expected that those patients who continue to attend a long-term follow-up clinic are preferentially those with the more severe disease. Indeed, some of those eight who were lost to follow-up probably failed to attend because they remained free of symptoms.
It is well established that the between-observer variation in assessments like the Ritchie articular index (RAI) is unacceptably high.t' As good technical reproducibility of the clinical and laboratory measures was of paramount importance in this study, the same physician carried out all the clinical assessments, and all the serum and synovial fluid samples for each patient were assayed for RFs (ELISA) on the same day. Furthermore, the clinic was always held at the same time of day (p.m.), thus reducing a possible diurnal variation. 
